Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 917 pages
Exam (elaborations)

Katzung’s Basic and Clinical Pharmacology 16th Edition Test Bank Exam Prep

Document preview thumbnail
Preview 4 out of 917 pages

Katzung’s Basic and Clinical Pharmacology 16th Edition Test Bank Exam Prep SEO Description Master pharmacology with this comprehensive chapter-by-chapter test bank for Katzung’s Basic and Clinical Pharmacology, 16th Edition. Includes NCLEX-style and NGN-style questions, SATA items, clinical case studies, pharmacotherapy scenarios, and detailed answer rationales. Strengthen clinical judgment with questions covering pharmacokinetics, pharmacodynamics, drug mechanisms, therapeutic uses, contraindications, adverse reactions, drug interactions, medication safety, nursing implications, and patient education across cardiovascular, endocrine, neurologic, antimicrobial, oncology, immunology, and toxicology pharmacology. SEO Keywords Katzung Basic and Clinical Pharmacology 16th Edition Test Bank pharmacology exam prep questions NCLEX pharmacology practice test bank pharmacokinetics and pharmacodynamics review medication safety and pharmacotherapy questions nursing pharmacology clinical judgment NGN drug mechanism of action practice questions

Content preview

KATZUNG'S BASIC AND
CLINICAL PHARMACOLOGY
16TH EDITION
• AUTHOR(S)TODD W.
VANDERAH




TEST BANK

,Question 1
A nurse is participating in a clinical trial for a new medication.
Which action best demonstrates the primary purpose of Phase
III clinical testing?
A. Determining whether the drug has any biologic activity in
healthy volunteers
B. Evaluating the medication's effectiveness and monitoring
adverse effects in a large patient population
C. Identifying the chemical structure of the investigational drug
D. Monitoring rare adverse effects after the medication has
been marketed
Correct Answer: B
Rationale:
Phase III trials evaluate efficacy and safety in a large group of
patients with the target condition before regulatory review.
Option A describes Phase I testing, which primarily evaluates
safety and dosage in a small group, often healthy volunteers.
Option C occurs during drug discovery and preclinical
development rather than clinical testing. Option D describes
post-marketing (Phase IV) surveillance.
Question 2

,A nurse is teaching a patient about generic medications. Which
statement by the nurse is most accurate?
A. Generic medications must have the same active ingredient
and demonstrate bioequivalence to the reference product.
B. Generic medications always have identical inactive
ingredients as the brand-name product.
C. Generic medications are less effective because they cost less.
D. Generic medications do not require regulatory review before
marketing.
Correct Answer: A
Rationale:
Generic medications are required to contain the same active
ingredient, dosage form, strength, route of administration, and
demonstrate bioequivalence to the reference drug. Inactive
ingredients may differ. Lower cost does not indicate lower
effectiveness. Regulatory review is required before approval.
Question 3
A nurse is reviewing a patient's medication history before
administering a newly prescribed drug. Which finding is most
important to report before administration?
A. The patient prefers taking medications with food.

, B. The patient has a documented allergy to a medication in the
same pharmacologic class.
C. The patient drinks coffee every morning.
D. The patient requests water instead of juice with medications.
Correct Answer: B
Rationale:
A documented allergy to a medication in the same class may
increase the risk of a serious hypersensitivity reaction and
requires clarification before administration. The remaining
findings are generally not contraindications unless specific drug
interactions exist.
Question 4
A patient asks why a medication was withdrawn from the
market several years after approval. Which response by the
nurse is most appropriate?
A. "The medication probably became too expensive to
manufacture."
B. "Post-marketing surveillance can identify rare adverse effects
that were not detected during clinical trials."
C. "The medication was likely less effective than all newer
drugs."

Connected book
 image
Publisher: 2023 ISBN: 9781260463309 Edition: Unknown

Document information

Uploaded on
July 5, 2026
Number of pages
917
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers
$37.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Sold
0
Followers
0
Items
184
Last sold
-


Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions